Imbalances in faecal and duodenal Bifidobacterium species composition in active and non-active coeliac disease - PubMed (original) (raw)
Imbalances in faecal and duodenal Bifidobacterium species composition in active and non-active coeliac disease
Maria Carmen Collado et al. BMC Microbiol. 2008.
Abstract
Background: Gut bifidobacteria are believed to influence immune-related diseases. The objective of this study was to assess the possible relationships between the gut bifidobacteria composition and coeliac disease (CD) in children. A total of 48 faecal samples (30 and 18 samples from active and no active CD patients, respectively) and 33 duodenal biopsy specimens of CD patients (25 and 8 samples from active and non-active CD patients, respectively) were analysed. Samples (30 faecal samples and 8 biopsies) from a control age-matched group of children were also included for comparative purposes. Gut Bifidobacterium genus and species were analyzed by real-time PCR.
Results: Active and non-active CD patients showed lower numbers of total Bifidobacterium and B. longum species in faeces and duodenal biopsies than controls, and these differences were particularly remarkable between active CD patients and controls. B. catenulatum prevalence was higher in biopsies of controls than in those of active and non-active CD patients, whereas B. dentium prevalence was higher in faeces of non-active CD patients than in controls. Correlations between levels of Bifidobacterium and B. longum species in faecal and biopsy samples were detected in both CD patients and controls.
Conclusion: Reductions in total Bifidobacterium and B. longum populations were associated with both active and non-active CD when compared to controls. These bacterial groups could constitute novel targets for adjuvant dietary therapies although the confirmation of this hypothesis would require further investigations.
Figures
Figure 1
Correlations of bifidobacterial groups of faecal and duodenal biopsy samples from all children (active and non-active CD patients and controls) under study. Data represent the positive samples. The line in the box is the median (50% percentile), with the lower line the lower 25% border (25% percentile) and the upper line the 75% (75% percentile) border. The end of the upper vertical line is the maximum data value, outliers not considered. The end of the lower vertical line is the lowest value, outliers not considered. The separate dots or asterisks indicate outliers. Significant differences (P < 0.050) were found between faeces and biopsy levels of every bifidobacterial group analysed when considering all subjects.
Similar articles
- Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease.
Collado MC, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y. Collado MC, et al. J Clin Pathol. 2009 Mar;62(3):264-9. doi: 10.1136/jcp.2008.061366. Epub 2008 Nov 7. J Clin Pathol. 2009. PMID: 18996905 - Duodenal and faecal microbiota of celiac children: molecular, phenotype and metabolome characterization.
Di Cagno R, De Angelis M, De Pasquale I, Ndagijimana M, Vernocchi P, Ricciuti P, Gagliardi F, Laghi L, Crecchio C, Guerzoni ME, Gobbetti M, Francavilla R. Di Cagno R, et al. BMC Microbiol. 2011 Oct 4;11:219. doi: 10.1186/1471-2180-11-219. BMC Microbiol. 2011. PMID: 21970810 Free PMC article. - Differences in faecal bacterial communities in coeliac and healthy children as detected by PCR and denaturing gradient gel electrophoresis.
Sanz Y, Sánchez E, Marzotto M, Calabuig M, Torriani S, Dellaglio F. Sanz Y, et al. FEMS Immunol Med Microbiol. 2007 Dec;51(3):562-8. doi: 10.1111/j.1574-695X.2007.00337.x. Epub 2007 Oct 4. FEMS Immunol Med Microbiol. 2007. PMID: 17919298 - Genus- and species-specific PCR primers for the detection and identification of bifidobacteria.
Matsuki T, Watanabe K, Tanaka R. Matsuki T, et al. Curr Issues Intest Microbiol. 2003 Sep;4(2):61-9. Curr Issues Intest Microbiol. 2003. PMID: 14503690 Review. - Salivary and fecal microbiota and metabolome of celiac children under gluten-free diet.
De Angelis M, Vannini L, Di Cagno R, Cavallo N, Minervini F, Francavilla R, Ercolini D, Gobbetti M. De Angelis M, et al. Int J Food Microbiol. 2016 Dec 19;239:125-132. doi: 10.1016/j.ijfoodmicro.2016.07.025. Epub 2016 Jul 19. Int J Food Microbiol. 2016. PMID: 27452636 Review.
Cited by
- Prevalence of delivery mode in an Italian nationwide cohort with celiac disease: a SIGENP multicenter retrospective study (the CD-deliver-IT).
Iorfida D, Valitutti F, Vestri A, D'Adamo G, Passaro T, Crocco M, Malerba F, Monzani A, Rabbone I, Pensabene L, Giancotti L, Graziano F, Citrano M, Ferretti F, Trovato CM, Pacenza C, Iasevoli M, Banzato C, Lubrano R, Montuori M; “Food-induced disease” study group of SIGENP. Iorfida D, et al. Ital J Pediatr. 2024 Jul 27;50(1):129. doi: 10.1186/s13052-024-01710-0. Ital J Pediatr. 2024. PMID: 39061072 Free PMC article. - Bifidobacterium longum subsp. longum BG-L47 boosts growth and activity of Limosilactobacillus reuteri DSM 17938 and its extracellular membrane vesicles.
Ermann Lundberg L, Pallabi Mishra P, Liu P, Forsberg MM, Sverremark-Ekström E, Grompone G, Håkansson S, Linninge C, Roos S. Ermann Lundberg L, et al. Appl Environ Microbiol. 2024 Jul 24;90(7):e0024724. doi: 10.1128/aem.00247-24. Epub 2024 Jun 18. Appl Environ Microbiol. 2024. PMID: 38888338 Free PMC article. - Unraveling the Microbiome-Human Body Axis: A Comprehensive Examination of Therapeutic Strategies, Interactions and Implications.
Olteanu G, Ciucă-Pană MA, Busnatu ȘS, Lupuliasa D, Neacșu SM, Mititelu M, Musuc AM, Ioniță-Mîndrican CB, Boroghină SC. Olteanu G, et al. Int J Mol Sci. 2024 May 20;25(10):5561. doi: 10.3390/ijms25105561. Int J Mol Sci. 2024. PMID: 38791599 Free PMC article. Review. - Probiotics in Allergy and Immunological Diseases: A Comprehensive Review.
Vijayan S, Kandi V, Palacholla PS, Rajendran R, Jarugu C, Ca J, Pravallika M, Reddy SC, Sucharitha AS. Vijayan S, et al. Cureus. 2024 Mar 8;16(3):e55817. doi: 10.7759/cureus.55817. eCollection 2024 Mar. Cureus. 2024. PMID: 38590477 Free PMC article. Review. - Bifidobacterium and the intestinal mucus layer.
Gutierrez A, Pucket B, Engevik MA. Gutierrez A, et al. Microbiome Res Rep. 2023 Sep 27;2(4):36. doi: 10.20517/mrr.2023.37. eCollection 2023. Microbiome Res Rep. 2023. PMID: 38045921 Free PMC article. Review.
References
- Stene LC, Honeyman MC, Hoffenberg EJ, Haas JE, Sokol RJ, Emery L, Taki I, Norris JM, Erlich HA, Eisenbarth GS, Rewers M. Rotavirus infection frequency and risk of coeliac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol. 2006;101:2333–2340. doi: 10.1111/j.1572-0241.2006.00741.x. - DOI - PubMed
- Collado MC, Calabuig M, Sanz Y. Differences between the faecal microbiota of coeliac children and healthy controls. Curr Issues Intest Microbiol. 2007;8:9–14. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical